174 related articles for article (PubMed ID: 17547889)
1. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
Denschlag D; Tan L; Patel S; Kerim-Dikeni A; Souhami L; Gilbert L
Am J Obstet Gynecol; 2007 Jun; 196(6):546.e1-7. PubMed ID: 17547889
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
[TBL] [Abstract][Full Text] [Related]
3. Analysis of FIGO Stage IIIc endometrial cancer patients.
McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
[TBL] [Abstract][Full Text] [Related]
4. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
[TBL] [Abstract][Full Text] [Related]
7. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
8. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
9. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
[TBL] [Abstract][Full Text] [Related]
10. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
11. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
[TBL] [Abstract][Full Text] [Related]
12. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
13. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators of survival in advanced endometrial cancer.
Behbakht K; Yordan EL; Casey C; DeGeest K; Massad LS; Kirschner CV; Wilbanks GD
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):363-7. PubMed ID: 7835775
[TBL] [Abstract][Full Text] [Related]
16. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
17. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.
Paramasivam S; Tripcony L; Crandon A; Quinn M; Hammond I; Marsden D; Proietto A; Davy M; Carter J; Nicklin J; Perrin L; Obermair A
J Clin Oncol; 2005 Sep; 23(25):5938-42. PubMed ID: 16087942
[TBL] [Abstract][Full Text] [Related]
19. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]